Citation Impact

Citing Papers

Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
2015
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Hypoxic control of metastasis
2016 Science
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
2019
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
2021
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Breast-cancer detection using blood-based infrared molecular fingerprints
2021 StandoutNobel
In Vitro Assays of Breast Cancer Stem Cells
2018 StandoutNobel
Combination cancer immunotherapy and new immunomodulatory targets
2015
Exercise-dependent regulation of the tumour microenvironment
2017
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma
2019 StandoutNobel
The spectrum of T cell metabolism in health and disease
2017
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
2017 StandoutNobel
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Targeting adenosine for cancer immunotherapy
2018
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
2016 StandoutNobel
Regulation of immunity and inflammation by hypoxia in immunological niches
2017
Purinergic regulation of the immune system
2016
Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system
2016 Nature
Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
2017
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Maintenance of redox homeostasis by hypoxia-inducible factors
2017 StandoutNobel
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
2020
Metabolism of immune cells in cancer
2020
Mitochondrial control of immunity: beyond ATP
2017
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
2019
CAR T‐cell immunotherapy: The path from the by‐road to the freeway?
2015
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Control of Metastasis by NK Cells
2017
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Increased vessel perfusion predicts the efficacy of immune checkpoint blockade
2018
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Hypoxia: Signaling the Metastatic Cascade
2016
Immunosuppressive activities of adenosine in cancer
2016
Combination cancer immunotherapies tailored to the tumour microenvironment
2015
Gsk3 is a metabolic checkpoint regulator in B cells
2017
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
2019
Mitochondria as multifaceted regulators of cell death
2019 Standout
The PI3K Pathway in Human Disease
2017 Standout
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
CD73: A potential biomarker for anti-PD-1 therapy
2015
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
2016 StandoutNobel
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment
2016
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
2017
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
2016
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Metabolic Regulation of the Immune Humoral Response
2017
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel

Works of Phaethon Philbrook being referenced

Targeted Elimination of Immunodominant B Cells Drives the Germinal Center Reaction toward Subdominant Epitopes
2017
Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
2014
Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells
2017
Immunological mechanisms of the antitumor effects of supplemental oxygenation
2015
Germinal Center Hypoxia Potentiates Immunoglobulin Class Switch Recombination
2016
Rankless by CCL
2026